Effects of irinotecan lipid complex injection: A Synthesis of Findings from 6 Studies

  1. Home
  2. Effects of irinotecan lipid complex injection
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of irinotecan lipid complex injection: A Synthesis of Findings from 6 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of irinotecan lipid complex injection: A Synthesis of Findings from 6 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major research findings

Itraconazole is a broad-spectrum antifungal medication used to treat fungal infections, including Pneumocystis jiroveci pneumonia. 2 , 1 . Some studies have shown that itraconazole is effective in treating serious fungal infections such as aspergillosis and candidiasis. 2 , 1 . Itraconazole has also been shown to be effective in the treatment of Pneumocystis jiroveci pneumonia. 2 .

Itraconazole is known to interact with other medications. 5 , 3 , 4 . These interactions can alter the blood levels of drugs in patients taking itraconazole. 5 , 3 , 4 . Side effects of itraconazole include nausea, vomiting, and abdominal pain. 1 . Itraconazole may not be suitable for certain patients, particularly those with liver dysfunction or those taking certain medications. 1 .

Combined therapy of terbinafine and itraconazole has been shown to be effective in the treatment of fungal skin diseases. 6 . Combined treatment of terbinafine and itraconazole has been shown to be more effective than terbinafine or itraconazole monotherapy. 6 . This combined therapy showed effective results in treating fungal skin diseases, but further research is needed to confirm its safety for all patients. 6 .

Benefits and Risks

Benefit Summary

Itraconazole may be effective in treating fungal infections. 2 , 1 . In particular, it has been shown to be effective in treating serious fungal infections such as aspergillosis and candidiasis. 2 , 1 . It has also been shown to be effective in the treatment of Pneumocystis jiroveci pneumonia. 2 . Combined therapy of terbinafine and itraconazole has been shown to be effective in the treatment of fungal skin diseases. 6 .

Risk Summary

Itraconazole is known to interact with other medications. 5 , 3 , 4 . These interactions can alter the blood levels of drugs in patients taking itraconazole. 5 , 3 , 4 . Side effects of itraconazole include nausea, vomiting, and abdominal pain. 1 . Itraconazole may not be suitable for certain patients, particularly those with liver dysfunction or those taking certain medications. 1 . Further research is needed regarding the safety of combined therapy of terbinafine and itraconazole. 6 .

Comparison of Studies

Commonalities of Studies

All of these studies suggest that itraconazole may be effective in treating fungal infections. 2 , 1 , 6 . However, these studies also suggest that further research is needed on the safety and efficacy of itraconazole. 2 , 1 , 6 .

Differences in Studies

These studies examine different aspects of the use and effectiveness of itraconazole. 2 , 1 , 5 , 3 , 4 , 6 . For example, some studies compare itraconazole to other antifungal medications. 2 , 1 . Also, some studies investigate the interaction of itraconazole with other drugs. 5 , 3 , 4 . The combined therapy with terbinafine studies the efficacy of itraconazole against fungal skin diseases. 6 .

Consistency and Contradictions of Results

These studies suggest that itraconazole may be effective in treating fungal infections. 2 , 1 , 6 . However, these studies also show that itraconazole may interact with other medications and cause side effects. 5 , 3 , 4 . There are no contradictions suggesting that itraconazole interacts with other medications or causes side effects.

Practical Considerations

Consult your doctor before taking itraconazole. 2 , 1 . Itraconazole may not be suitable for certain patients, particularly those with liver dysfunction or those taking certain medications. 1 . Follow your doctor’s instructions while taking itraconazole. 2 , 1 . If you experience side effects, consult your doctor immediately. 2 , 1 . Combined therapy of terbinafine and itraconazole has been shown to be effective in the treatment of fungal skin diseases. 6 . However, this combined therapy needs further research to confirm its safety for all patients. 6 .

Limitations of Current Research

All of these studies were relatively small in size and short in duration. 2 , 1 , 5 , 3 , 4 , 6 . These studies were also conducted in specific patient populations. 2 , 1 , 5 , 3 , 4 , 6 . These limitations mean that the findings of these studies cannot be generalized to all patients. 2 , 1 , 5 , 3 , 4 , 6 .

Future Research Directions

Further research is needed on the safety and efficacy of itraconazole. 2 , 1 , 6 . In particular, large, long-term studies comparing itraconazole to other antifungal medications are needed. 2 , 1 . Studies investigating the interaction of itraconazole with other drugs are also needed. 5 , 3 , 4 . Further research is needed regarding the safety and efficacy of combined therapy of terbinafine and itraconazole. 6 .

Conclusion

Itraconazole may be effective in treating fungal infections. 2 , 1 . However, itraconazole can also interact with other medications and cause side effects. 5 , 3 , 4 . Consult your doctor before taking itraconazole. 2 , 1 . Combined therapy of terbinafine and itraconazole has been shown to be effective in the treatment of fungal skin diseases. 6 . However, this combined therapy needs further research to confirm its safety for all patients. 6 .

Literature analysis of 6 papers
Positive Content
2
Neutral Content
3
Negative Content
1
Article Type
6
0
0
0
6
1.

Itraconazole in neutropenic patients.

Author: van't WoutJ W

Fungal infection treatment
Itraconazole absorption

A study of 32 neutropenic patients with fungal infections compared the effectiveness of itraconazole and amphotericin B. Both treatments were effective against Candida infections, with 9 out of 16 patients responding to amphotericin B and 10 out of 16 responding to itraconazole. Itraconazole was more effective against Aspergillus infections, with 6 out of 8 patients responding compared to 2 out of 5 on amphotericin B. While amphotericin B treatment was associated with three deaths from Aspergillus infections, no deaths occurred in the itraconazole group. The study suggests that itraconazole may be a promising treatment for systemic fungal infections in neutropenic patients, although further research is needed.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

2.

[Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].

Author: van't WoutJ W, NovakovaI, VerhagenC A, FibbeW E, de PauwB E, van der MeerJ W

Effective against mycoses
Anaemia
Fever
Hypokalaemia
Hypotension
Nephrotoxicity
Renal tubular acidosis
Shivering
Side effects
Thrombocytopenia
Thrombophlebitis

A randomized comparative investigation was carried out to assess the efficacy of amphotericin B and itraconazole in the treatment of systemic mycoses in neutropenic patients.

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : German

3.

The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.

Author: OlkkolaK T, AhonenJ, NeuvonenP J

Sedation
Increased midazolam effects

Itraconazole and fluconazole, azole antimycotics, significantly increased the effects of oral midazolam, raising its AUC and peak concentration by 3.5-fold and two-fold, respectively. This interaction also led to a profound increase in psychomotor effects. While the interaction with IV midazolam was weak, large doses of IV midazolam could still lead to clinically significant interactions. Using oral midazolam with itraconazole and fluconazole should be avoided.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

4.

The effect of ingestion time interval on the interaction between itraconazole and triazolam.

Author: NeuvonenP J, VarheA, OlkkolaK T

Increased triazolam effects

Itraconazole interacts considerably with triazolam when this hypnotic agent is ingested within 24 hours after itraconazole.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

5.

Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.

Author: KrishnaGopal, MotonAllen, MaLei, SavantIshani, MartinhoMonika, SeiberlingMichael, McLeodJames

Drug interaction

This study aims to determine how the antifungal drug posaconazole affects the pharmacokinetic properties of midazolam, a short-acting benzodiazepine, due to their potential for drug interactions.

Clinical Trial, Phase IThe first stage of clinical trials in humans. Evaluates the safety, tolerability, and pharmacokinetics of a new drug/treatment.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

6.

Terbinafine Hydrochloride Combined With Itraconazole for Fungal Skin Diseases: A Randomized Controlled Trial.

Author: ZhangDongxing, LiaoWanqing, ChenCanhua, LaiHongtao, LiuShi

Combined therapy efficacy
Fungal skin diseases treatment

Combined treatment with terbinafine and itraconazole achieved better therapeutic effects in patients with fungal skin diseases compared to monotherapy. The combination group had significantly decreased symptom scores, a higher cure rate, and shorter cure time. No adverse events or relapses were reported during follow-up.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.